6 months ago
AXSM
AnalystsAndrew TsaiAndrew Tsai's Stock Forecasts
AnalystsAndrew Tsai
Analyst Ranking
Top 28%
#1555 out of 5550 analysts
Average Return
+4.25%
Win Rate
48%16 out of 33
Risk vs Reward
Poor
Good
Andrew Tsai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cerevel Therapeutics Holdings IncCERE | +139.30% | $14.20 | $33.98 | 2020-11-23 - 2021-11-22 | Strong Buy |
Stoke Therapeutics IncSTOK | +119.74% | $13.22 | $29.05 | 2025-07-18 - 2026-07-17 | Strong Buy |
Definium Therapeutics IncDFTX | +115.23% | $16.88 | $36.33 | 2026-01-30 - 2026-10-30 | Strong Buy |
Bridgebio Pharma IncBBIO | +74.21% | $47.69 | $83.08 | 2025-07-14 - 2026-07-13 | Strong Buy |
Axsome Therapeutics IncAXSM | +72.32% | $98.50 | $169.74 | 2025-04-07 - 2026-04-06 | Strong Buy |
Andrew Tsai Analyst Color
Get additional color on Andrew Tsai's coverage of popular stocks
a year ago
BIIB
2 years ago
SRPT
Andrew Tsai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Absci CorpABSI | 1 | Strong Buy | $14.00 | +25.79% | Initiates Coverage On | 2 days ago |
Ataibeckley IncATAI | 3 | Hold | $7.50 | +2.04% | Downgrades | 3 months ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $275.00 | +90.40% | Maintains | 6 months ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $18.00 | +55.57% | Initiates Coverage On | 6 months ago |
Bright Minds Biosciences IncDRUG | 1 | Strong Buy | $145.00 | N/A | Initiates Coverage On | 7 months ago |
Definium Therapeutics IncDFTX | 1 | Strong Buy | $30.00 | -17.42% | Initiates Coverage On | 9 months ago |
Vistagen Therapeutics IncVTGN | 3 | Hold | $0.90 | +435.71% | Downgrades | 10 months ago |
Moderna IncMRNA | 1 | Hold | $30.00 | -86.47% | Initiates Coverage On | a year ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $450.00 | +57.38% | Maintains | a year ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $32.00 | +322.16% | Initiates Coverage On | a year ago |
Alto Neuroscience IncANRO | 2 | Strong Buy | $25.00 | +10.62% | Maintains | a year ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Hold | $20.00 | N/A | Downgrades | a year ago |
Akero Therapeutics IncAKRO | 1 | Hold | $56.00 | N/A | Downgrades | a year ago |
Biogen IncBIIB | 1 | Strong Buy | $190.00 | N/A | Initiates Coverage On | a year ago |
Sarepta Therapeutics IncSRPT | 3 | Strong Buy | $35.00 | N/A | Maintains | a year ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | a year ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $110.00 | N/A | Maintains | a year ago |
Rocket Pharmaceuticals IncRCKT | 2 | Hold | $2.50 | N/A | Downgrades | a year ago |
Ke Holdings IncBEKE | 2 | Strong Buy | $27.00 | N/A | Maintains | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 1 | Hold | $0.50 | N/A | Downgrades | 2 years ago |
Relmada Therapeutics IncRLMD | 2 | Strong Buy | $13.00 | N/A | Upgrades | 2 years ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 1 | Hold | $21.00 | N/A | Downgrades | 3 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $3.00 | N/A | Initiates Coverage On | 4 years ago |
Leonabio IncLONA | 2 | Hold | $30.00 | N/A | Downgrades | 4 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $70.00 | N/A | Maintains | 5 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 6 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $23.00 | N/A | Assumes | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.